Kangstem Biotech Co., Ltd. (KOSDAQ: 217730)

Kangstem Biotech Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 10, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	78,812	133,971	109,830	124,057	196,458	169,714
Market Cap Growth	25.43%	21.98%	-11.47%	-36.85%	15.76%	-62.62%
Enterprise Value	56,219	129,761	85,183	115,828	180,137	145,899
Last Close Price	1406.00	2395.00	2514.77	2840.52	5613.97	5777.21
PE Ratio	-	-4.43	-4.71	-3.71	-6.78	-4.89
PS Ratio	5.25	10.55	6.74	10.00	21.50	28.26
PB Ratio	1.53	2.67	2.08	1.74	4.04	2.47
P/FCF Ratio	-9.14	-7.49	-5.61	-5.74	-11.53	-5.92
P/OCF Ratio	-9.98	-8.12	-5.82	-7.30	-14.04	-12.74
EV/Sales Ratio	4.23	10.21	5.23	9.34	19.71	24.30
EV/EBITDA Ratio	-8.32	-6.88	-5.10	-6.14	-11.45	-6.93
EV/EBIT Ratio	-6.82	-5.70	-4.14	-5.09	-9.62	-6.30
EV/FCF Ratio	-3.26	-7.25	-4.35	-5.36	-10.58	-5.09
Debt / Equity Ratio	0.15	0.27	0.25	0.20	0.37	0.45
Debt / FCF Ratio	-0.44	-0.76	-0.68	-0.65	-1.07	-1.08
Asset Turnover	0.19	0.16	0.18	0.13	0.09	0.06
Inventory Turnover	13.27	21.16	18.57	17.37	26.05	5.88
Quick Ratio	2.44	2.07	2.73	3.38	3.18	2.36
Current Ratio	3.09	2.55	3.22	3.80	3.67	2.69
Return on Equity (ROE)	-25.70%	-45.17%	-32.55%	-36.40%	-33.65%	-45.39%
Return on Assets (ROA)	-18.75%	-17.59%	-13.99%	-15.31%	-11.93%	-15.49%
Return on Capital (ROIC)	-23.01%	-21.93%	-16.97%	-18.68%	-14.06%	-17.58%
Earnings Yield	-14.00%	-16.38%	-18.42%	-17.21%	-9.40%	-14.52%
FCF Yield	-21.86%	-13.35%	-17.82%	-17.43%	-8.67%	-16.89%
Buyback Yield / Dilution	-31.71%	-7.02%	-36.23%	-24.89%	-6.99%	-13.71%
Total Shareholder Return	-31.71%	-7.02%	-36.23%	-24.89%	-6.99%	-13.71%

Source: S&P Capital IQ. Standard template. Financial Sources.